Axe Compute Inc. (AGPU) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Axe Compute Inc. stock (AGPU) is currently trading at $1.53. Axe Compute Inc. PS ratio (Price-to-Sales) is 3.55. WallStSmart rates AGPU as Sell.
- AGPU PE ratio analysis and historical PE chart
- AGPU PS ratio (Price-to-Sales) history and trend
- AGPU intrinsic value — DCF, Graham Number, EPV models
- AGPU stock price prediction 2025 2026 2027 2028 2029 2030
- AGPU fair value vs current price
- AGPU insider transactions and insider buying
- Is AGPU undervalued or overvalued?
- Axe Compute Inc. financial analysis — revenue, earnings, cash flow
- AGPU Piotroski F-Score and Altman Z-Score
- AGPU analyst price target and Smart Rating
Axe Compute Inc.
📊 No data available
Try selecting a different time range

Smart Analysis
Axe Compute Inc. (AGPU) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book. Concerns around market cap and operating margin. Significant fundamental concerns warrant caution or avoidance.
Axe Compute Inc. (AGPU) Key Strengths (1)
Trading at 1.43x book value, attractively priced
Axe Compute Inc. (AGPU) Areas to Watch (5)
Losing money on operations
Revenue declining -7.40%, a shrinking business
Very low institutional interest at 1.01%
Micro-cap company with very limited liquidity and high volatility
Revenue is fairly priced at 3.55x sales
Axe Compute Inc. (AGPU) Detailed Analysis Report
Overall Assessment
This company scores 21/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 1 register as strengths (avg 8.0/10) while 5 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book. Valuation metrics including Price/Book (1.43) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Operating Margin, Revenue Growth, Institutional Own.. Some valuation metrics including Price/Sales (3.55) suggest expensive pricing. Growth concerns include Revenue Growth at -7.40%, which may limit upside. Profitability pressure is visible in Operating Margin at -90654.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at -90654.00% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -7.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AGPU Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AGPU's Price-to-Sales ratio of 3.55x sits near its historical average of 3.81x (61th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 81% below its historical high of 18.64x set in Oct 2025, and 472% above its historical low of 0.62x in Oct 2022. Over the past 12 months, the PS ratio has expanded from ~3.0x, reflecting growing market expectations outpacing revenue growth.
Compare AGPU with Competitors
Top SOFTWARE - INFRASTRUCTURE stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Axe Compute Inc. (AGPU) · TECHNOLOGY › SOFTWARE - INFRASTRUCTURE
The Big Picture
Axe Compute Inc. operates as a stable business with moderate growth and solid fundamentals. Revenue reached 2M with 7% decline year-over-year.
Key Findings
Spending 32% of revenue (528,557) on R&D, reinforcing its commitment to innovation and future growth.
Revenue contracted 7% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -2M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive moves, and regulatory changes that could impact Axe Compute Inc..
Bottom Line
Axe Compute Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 10:12:49 AM
About Axe Compute Inc.(AGPU)
NASDAQ
TECHNOLOGY
SOFTWARE - INFRASTRUCTURE
USA
Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. The company is headquartered in Pittsburgh, Pennsylvania.